Chemours
453 hedge funds and large institutions have $3.23B invested in Chemours in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 107 increasing their positions, 166 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
24% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 66
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
36% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 166
Holders
453
Holding in Top 10
4
Calls
$57.3M
Puts
$69.1M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$28.1M | |
| 3 | +$25.9M | |
| 4 |
Bank of New York Mellon
New York
|
+$17.2M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$13.7M |
Top Sellers
| 1 | -$41.5M | |
| 2 | -$36.2M | |
| 3 | -$26.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$9.84M |